BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNA fingerprint
,
Lipitor
,
rs4950928
,
ZBTB7A
,
Coagulation
,
HIV infection
,
Intestine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
semaphorins 5
Summary
General Info
Curated Studies
Most Correlated Studies
Thalamic dorsal lateral geniculate nuclei of mice with SEMA6A knockout
Mouse blood vascular and lymphatic endothelial cell gene expression profiling
Umbilical vein endothelial cells expressing Forkhead Box Protein P1 (FOXP1) siRNA
Keratinocytes HaCat cell line with BCL-3 overexpression
Whole embryos with CHD7 whirligig mutation
Explore Curated Studies Results
Literature
Most Relevant Literature
Emerging roles and mechanisms of semaphorins activity in cancer.
Semaphorins and Their Roles in Breast Cancer: Implications for Therapy Resistance.
An 8-month-old boy with infantile nephrotic syndrome caused by semaphorin 3B-associated membranous n…
The role of semaphorins in cardiovascular diseases: Potential therapeutic targets and novel biomarke…
Adult expression of Semaphorins and Plexins is essential for motor neuron survival.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH
Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Ca…
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
Vascular Injury in Mechanical Ventilation: a Proof-of-Concept Study
Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancr…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ